Rating History for Myriad Genetics (MYGN) by Credit Suisse
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/4/2015 | N/A | Downgrade | Underperform (Neutral) |
30.00 (35.00) |
38.12 (3.19) |
-91.63% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 2/4/2015 | N/A | Downgrade | Underperform (Neutral) |
30.00 (35.00) |
38.12 (3.19) |
-91.63% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||